Skip to main content
logo
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.370
+0.090 (2.74%)
Oct 9, 2026, 4:00 PM EDT - Market closed

IMDX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
110215402138200
Market Cap Growth
4.73%436.55%94.02%-45.76%-80.98%24.52%
Enterprise Value
95199411414162
Last Close Price
3.377.502.382.506.4243.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
66.0453.0221.3013.7439.7491.06
PB Ratio
--6.83-3.260.810.963.07

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
56.9849.1821.649.6015.0773.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.12-0.11-0.300.110.090.09
Debt / EBITDA Ratio
0.010.010.010.00--
Net Debt / Equity Ratio
0.710.260.41-0.26-0.43-0.43
Net Debt / EBITDA Ratio
0.440.290.230.320.721.44
Net Debt / FCF Ratio
0.490.320.230.280.340.74
Asset Turnover
0.040.130.030.020.010.02
Inventory Turnover
1.904.09----
Quick Ratio
1.751.051.411.381.852.50
Current Ratio
2.001.271.621.492.112.77
Return on Equity (ROE)
---910.86%-76.26%-35.52%-88.37%
Return on Assets (ROA)
-57.82%-62.66%-26.42%-15.91%-13.88%-13.82%
Return on Capital Employed (ROCE)
-193.10%-222.90%-83.60%-32.90%-32.80%-16.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-44.76%-23.36%-151.40%-134.52%-191.48%-32.03%
FCF Yield
-28.11%-11.80%-52.92%-114.30%-131.09%-19.08%
Buyback Yield / Dilution
-52.34%-133.16%-70.84%-38.10%-24.61%-35.80%